R20L (p.Arg20Leu) variant of IRS1 (Insulin receptor substrate 1)

R20L (p.Arg20Leu) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.66 / 1. The record also includes population frequency data.

R20L (p.Arg20Leu) variant details